Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04903223 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Liver Adiposity Effects on Pediatric Statin

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Primary completion date: Jun 30, 2026 to Oct 30, 2026
    • Study completion date: Dec 31, 2026 to Mar 31, 2027
    v10
  2. Notable Primary completion date: Nov 1, 2025 to Jun 30, 2026
    • Study completion date: Nov 1, 2025 to Dec 31, 2026
    v9
  3. Notable Primary and study completion dates: Jan 30, 2025 to Nov 1, 2025v8
  4. Notable Primary and study completion dates: Apr 30, 2024 to Jan 30, 2025v7
  5. Minor Re-verified, no change to tracked fieldsv6
Show 4 earlier versionsHide 4 earlier versions
  1. Minor Eligibility criteria expanded, about 23 wordsv5
  2. Notable Primary and study completion dates: Nov 1, 2023 to Apr 30, 2024
    • Eligibility criteria expanded, about 32 words
    v4
  3. Minor 2 versions Re-verified since Oct 26, 2021, no change to tracked fieldsv2-v3
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Single center, open-label, prospective investigation to quantify the effects hepatocellular fat has on hepatic statin transport and response in children and adolescents in obese and non-obese children and adolescents 8-21 years of age with normal, wild-type SLCO1B1 c.521TT genotype that are dosed rosuvastatin
Trial Details
NCT Number NCT04903223
Lead Sponsor Children's Mercy Hospital Kansas City
Conditions
(from sponsor)
Cholesterol; Lipidosis
Related terms Lipidoses
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov